A heterozygous LAMA5 variant may contribute to slowly progressive, vinculin-enhanced familial FSGS and pulmonary defects
Authors:
- Jun-Ya KaimoriJKJun-Ya Kaimori
- Yamato KikkawaYKYamato Kikkawa
- Daisuke MotookaDMDaisuke Motooka
- Tomoko Namba-HamanoTNTomoko Namba-Hamano
- Ayako TakuwaATAyako Takuwa
- Kaori KobayashiKKKaori Kobayashi
- Arisa TanigawaATArisa Tanigawa
- Yuko KotaniYKYuko Kotani
- Yoshihiro UnoYUYoshihiro Uno
- Kazuto YoshimiKYKazuto Yoshimi
- Koki HattoriKHKoki Hattori
Open Access
- 8 December 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (23)
Abstract
The LAMA5 gene encodes laminin α5, an indispensable component of glomerular basement membrane and other types of basement membrane. A homozygous pathological variant in LAMA5 is known to cause a systemic developmental syndrome including glomerulopathy. However, the roles of heterozygous LAMA5 gene variants in human renal and systemic diseases have remained unclear. We performed whole-exome sequencing analyses of a family with slowly progressive nephropathy associated with hereditary focal segmental glomerulosclerosis, and we identified what we believe to be a novel probable pathogenic variant of LAMA5 , NP_005551.3:p.Val3687Met. In vitro analyses revealed cell type–dependent changes in secretion of variant laminin α5 laminin globular 4-5 (LG4-5) domain. Heterozygous and homozygous knockin mice with a corresponding variant of human LAMA5 , p.Val3687Met, developed focal segmental glomerulosclerosis–like pathology with reduced laminin α5 and increased glomerular vinculin levels, which suggested that impaired cell adhesion may underlie this glomerulopathy. We also identified pulmonary defects such as bronchial deformity and alveolar dilation. Reexaminations of the family revealed phenotypes compatible with reduced laminin α5 and increased vinculin levels in affected tissues. Thus, the heterozygous p.Val3687Met variant may cause a new syndromic nephropathy with focal segmental glomerulosclerosis through possibly defective secretion of laminin α5. Enhanced vinculin may be a useful disease marker.Keywords
Funding Information
- the Osaka Medical Research Foundation for Intractable Disease (NA)
This publication has 41 references indexed in Scilit:
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- The glomerular basement membraneExperimental Cell Research, 2012
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Mutations in the human laminin β2 (LAMB2) gene and the associated phenotypic spectrumaHuman Mutation, 2010
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- The LG1-3 Tandem of Laminin α5 Harbors the Binding Sites of Lutheran/Basal Cell Adhesion Molecule and α3β1/α6β1 IntegrinsJournal of Biological Chemistry, 2007
- Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosisKidney International, 2001